OTCMKTS:MRMD MariMed (MRMD) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free MRMD Stock Alerts $0.27 +0.01 (+3.89%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$0.26▼$0.2750-Day Range$0.20▼$0.3052-Week Range$0.20▼$0.55Volume126,577 shsAverage Volume457,623 shsMarket Capitalization$100.23 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Get MariMed alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About MariMed Stock (OTCMKTS:MRMD)MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature's Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty's Eddies brand and ice creams under Emack & Bolio's brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.Read More MRMD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MRMD Stock News HeadlinesApril 21, 2024 | msn.comCannabis Investors Share 'Chips Make Chunks' Wisdom For Business Expansion At Benzinga ConferenceApril 17, 2024 | benzinga.com'A F—ed-Up Situation,' Says MariMed CCO About How State Regulations Complicate Cannabis Edibles StrategyApril 25, 2024 | Stansberry Research (Ad)Mysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.April 16, 2024 | americanbankingnews.comCritical Review: MariMed (OTCMKTS:MRMD) versus Cronos Group (NASDAQ:CRON)April 13, 2024 | uk.investing.comMariMed Closes Acquisition of Thrive Dispensary in Casey, The Company's Fifth Illinois DispensaryApril 11, 2024 | msn.comMariMed Is On A Roll: Partners With Two Iconic Music Venues In Boston, Acquires Another Illinois Cannabis DispensaryApril 11, 2024 | finance.yahoo.comMariMed Closes Acquisition of Thrive Dispensary in Casey, The Company’s Fifth Illinois DispensaryApril 11, 2024 | finance.yahoo.comMariMed Closes Acquisition of Thrive Dispensary in Casey, The Company’s Fifth Illinois DispensaryApril 25, 2024 | Stansberry Research (Ad)Mysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.April 11, 2024 | globenewswire.comMariMed Closes Acquisition of Thrive Dispensary in Casey, The Company's Fifth Illinois DispensaryApril 10, 2024 | bizjournals.comMass. cannabis firm sponsors MGM Music Hall, House of BluesApril 10, 2024 | globenewswire.comMariMed Partners with Iconic Boston Music VenuesApril 10, 2024 | globenewswire.comMariMed Partners with Iconic Boston Music VenuesApril 9, 2024 | finanznachrichten.deMariMed Inc.: MariMed Closes Acquisition of Second Maryland DispensaryApril 9, 2024 | globenewswire.comMariMed Closes Acquisition of Second Maryland DispensaryApril 8, 2024 | globenewswire.comMariMed Announces First Quarter 2024 Earnings DateMarch 27, 2024 | msn.com'Unsexy' Alternative, Operating Within Constraints, Consistency & Love: 3 Experts On Making Cannabis Businesses Self-SustainableMarch 12, 2024 | globenewswire.comA Bigger Dispensary Opens in the Town of “Big Things” as MariMed Opens Larger, Permanent Thrive Dispensary in Casey, IllinoisMarch 9, 2024 | seekingalpha.comMariMed Inc. (MRMD) Q4 2023 Earnings Call TranscriptMarch 8, 2024 | finance.yahoo.comMariMed Inc. (PNK:MRMD) Q4 2023 Earnings Call TranscriptMarch 8, 2024 | finanznachrichten.deMariMed Inc.: MariMed Reports Fourth Quarter and Full Year 2023 EarningsMarch 7, 2024 | msn.comMariMed Reports 'Another Year Of Strong Operational And Financial Performance' And More To Come In 2024March 7, 2024 | investorplace.comMRMD Stock Earnings: MariMed Beats Revenue for Q4 2023March 6, 2024 | benzinga.comMariMed's Earnings: A PreviewMarch 6, 2024 | globenewswire.comMariMed Reports Fourth Quarter and Full Year 2023 EarningsMarch 4, 2024 | finance.yahoo.comMariMed’s Betty’s Eddies™ Introduces Ache Away Eddies PM For Those Who Chews A Pain-Free Night’s SleepMarch 4, 2024 | globenewswire.comMariMed's Betty's Eddies™ Introduces Ache Away Eddies PM For Those Who Chews A Pain-Free Night's SleepSee More Headlines Receive MRMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MariMed and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/15/2021Today4/25/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medicinals & botanicals Sub-IndustryN/A Current SymbolOTCMKTS:MRMD CUSIPN/A CIK1522767 Webmarimedadvisors.com Phone(617) 795-5140FaxN/AEmployees643Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-16,030,000.00 Net Margins-10.79% Pretax Margin-4.44% Return on Equity-1.84% Return on Assets-0.72% Debt Debt-to-Equity Ratio0.97 Current Ratio1.67 Quick Ratio0.85 Sales & Book Value Annual Sales$148.60 million Price / Sales0.65 Cash Flow$0.03 per share Price / Cash Flow8.92 Book Value$0.19 per share Price / Book1.36Miscellaneous Outstanding Shares375,130,000Free Float298,041,000Market Cap$96.97 million OptionableNot Optionable Beta2.85 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Jon R. Levine (Age 59)Co-Founder, CEO, Interim CFO, President, Secretary, Treasurer & Director Comp: $481.74kMr. Timothy Shaw (Age 46)Chief Operating Officer Comp: $445.86kMr. Jonathan W. Rider (Age 59)Chief Information Officer Mr. Steve Wayne WestVice President of Investor RelationsMr. Howard SchacterChief Communications OfficerMs. Sara Gullickson (Age 39)Vice President of Marketing Mr. Ryan CrandallChief Revenue OfficerMr. Charles Holt FinnieChief Strategy OfficerMore ExecutivesKey CompetitorsFitLife BrandsNASDAQ:FTLFJushiOTCMKTS:JUSHFMediWoundNASDAQ:MDWDExactusOTCMKTS:EXDINatural Alternatives InternationalNASDAQ:NAIIView All Competitors MRMD Stock Analysis - Frequently Asked Questions How have MRMD shares performed in 2024? MariMed's stock was trading at $0.2748 at the start of the year. Since then, MRMD shares have decreased by 5.9% and is now trading at $0.2585. View the best growth stocks for 2024 here. Are investors shorting MariMed? MariMed saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 15,300 shares, a decrease of 55.5% from the March 31st total of 34,400 shares. Based on an average trading volume of 805,900 shares, the days-to-cover ratio is currently 0.0 days. View MariMed's Short Interest. How were MariMed's earnings last quarter? MariMed Inc. (OTCMKTS:MRMD) issued its quarterly earnings results on Monday, November, 15th. The company reported $0.01 earnings per share for the quarter. The company had revenue of $33.21 million for the quarter. MariMed had a negative net margin of 10.79% and a negative trailing twelve-month return on equity of 1.84%. What guidance has MariMed issued on next quarter's earnings? MariMed issued an update on its FY 2024 earnings guidance on Wednesday, March, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $156.0 million-$159.0 million, compared to the consensus revenue estimate of $173.8 million. What other stocks do shareholders of MariMed own? Based on aggregate information from My MarketBeat watchlists, some companies that other MariMed investors own include KushCo (KSHB), Organigram (OGI), Auxly Cannabis Group (CBWTF), CNBX Pharmaceuticals (CNBX), Supreme Cannabis (SPRWF), Gran Tierra Energy (GTE), Pennsylvania Real Estate Investment Trust (PEI), GB Sciences (GBLX), Medical Marijuana (MJNA) and Smart Cannabis (SCNA). How do I buy shares of MariMed? Shares of MRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:MRMD) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MariMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
